The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01) |
93.847 |
RFA-DK-14-504 |
| Immunobiology of Xenotransplantation (U19) |
93.855, 93.856 |
RFA-AI-14-047 |
| Immunobiology of Xenotransplantation (U01) |
93.855, 93.856 |
RFA-AI-14-048 |
| NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3) |
93.853 |
PAR-14-288 |
| NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44) |
93.853 |
PAR-14-289 |
| NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44) |
93.853 |
PAR-14-287 |
| NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01) |
93.853 |
PAR-14-286 |
| Centers of Cancer Nanotechnology Excellence (CCNEs) (U54) |
93.393, 93.394, 93.395, 93.396 |
RFA-CA-14-013 |
| Innovative Research in Cancer Nanotechnology (IRCN) (U01) |
93.393, 93.394, 93.395, 93.396 |
PAR-14-285 |
| High Throughput Screening (HTS) to Discover Chemical Probes (R01) |
93.173, 93.242, 93.273, 93.279, 93.394, 93.395, 93.846, 93.847, 93.853, 93.865, 93.866, 93.867 |
PAR-14-284 |
| High Throughput Screening (HTS) to Discover Chemical Probes (R21) |
93.173, 93.242, 93.273, 93.279, 93.394, 93.395, 93.846, 93.865, 93.866, 93.867 |
PAR-14-283 |
| The Electronic Medical Records and Genomics (eMERGE) Network, Phase III Central Sequencing and Genotyping Facility (U01) |
93.172 |
RFA-HG-14-027 |
| The Electronic Medical Records and Genomics (eMERGE) Network, Phase III Coordinating Center (U01) |
93.172 |
RFA-HG-14-026 |
| Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21) |
93.279 |
RFA-DA-15-012 |
| Extracellular Vesicles in HIV/AIDS and Substance Abuse (R01) |
93.279 |
RFA-DA-15-011 |
| Summer Research Training in Aging for Medical Students (T35) |
93.866 |
RFA-AG-15-009 |
| Neuroscience Information Framework (U24) |
93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.361, 93.853, 93.865, 93.866, 93.867 |
RFA-DA-15-009 |
| Hazmat Training at DOE Nuclear Weapons Complex (UH4) |
93.142 |
RFA-ES-14-009 |
| U.S.-China Program for Research Toward a Cure for HIV/AIDS (R01) |
93.242, 93.273, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.853, 93.855, 93.856, 93.865 |
RFA-AI-14-057 |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22) |
93.853 |
PAR-14-282 |
| Connectomes Related to Human Disease (U01) |
93.242, 93.273, 93.279, 93.853, 93.866, 93.867 |
PAR-14-281 |
| Pilot Centers for Precision Disease Modeling (U54) |
93.351 |
PAR-14-280 |
| Obstetric-Fetal Pharmacology Research Centers (OPRC) (U54) |
93.865 |
RFA-HD-14-013 |
| Aging and Neuromuscular Junctions (R01) |
93.866 |
RFA-AG-15-008 |
| Discovery of in vivo Chemical Probes (R01) |
93.173, 93.242, 93.273, 93.279, 93.394, 93.395, 93.846, 93.865, 93.866, 93.867 |
PAR-14-279 |
| In-vivo Methods for Assessing Placental Development and Function (STTR) [R41/R42] |
93.286, 93.865 |
RFA-HD-15-019 |
| In-vivo Methods for Assessing Placental Development and Function (SBIR) [R43/R44] |
93.286, 93.865 |
RFA-HD-15-018 |
| Ethical, Legal, and Social Implications (ELSI) of Genomic Research Exploratory/Developmental Research Program (R21) |
93.113, 93.172, 93.173, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855, 93.856, 93.865, 93.866 |
PA-14-278 |
| Ethical, Legal, and Social Implications (ELSI) of Genomic Research Regular Research Program (R01) |
93.113, 93.172, 93.173, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855, 93.856, 93.865, 93.866 |
PA-14-276 |
| Ethical, Legal, and Social Implications (ELSI) of Genomic Research Small Research Grant Program (R03) |
93.113, 93.172, 93.279, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855, 93.856, 93.865, 93.866, 93.989 |
PA-14-277 |
| Blood Pressure Measurement Technologies for Low-Resource Settings in the US and India (U01) |
93.286 |
RFA-EB-14-002 |
| Revision Applications for Research Using Aged Animal Models to Study Chronic Disorders of Heart, Lung, Blood, and Sleep (R01) |
93.233, 93.837, 93.838, 93.839 |
RFA-HL-15-005 |
| The Electronic Medical Records and Genomics (eMERGE) Network, Phase III Study Investigators (U01) |
93.172 |
RFA-HG-14-025 |
| Cardiovascular Development Consortium (UM1) |
93.837 |
RFA-HL-15-013 |
| Pediatric Cardiac Genomics Consortium (UM1) |
93.837, 93.865 |
RFA-HL-15-012 |
| Development of Novel Therapeutics for Select Anaerobic Protozoa (R21/R33) |
93.855, 93.856 |
RFA-AI-14-015 |
| The National Drug Abuse Treatment Clinical Trials Network (UG1) |
93.279 |
RFA-DA-15-008 |
| Medically Assisted Reproduction: Investigation of Mechanisms Underlying the Adverse Outcomes and Development of New and Improved Methods to Overcome the Adverse Outcomes (R21) |
93.865 |
PAR-14-273 |
| Medically Assisted Reproduction: Investigation of Mechanisms Underlying the Adverse Outcomes and Development of New and Improved Methods to Overcome the Adverse Outcomes (R01) |
93.865 |
PAR-14-272 |
| NIDDK Cooperative Hematology Specialized Core Centers (U54) |
93.847 |
RFA-DK-14-001 |
Search Results 7561-7600 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
